Kodama J, Ikuhashi H, Hongo A, Mizutani Y, Miyagi Y, Yoshinouchi M, Kobashi Y, Okuda H, Kudo T
Dept. of Obstetrics and Gynecology, Okayama University Medical School.
Gan To Kagaku Ryoho. 1999 Jan;26(1):89-92.
Twenty-five patients with advanced cervical cancer (IIb-IVa) were treated with neoadjuvant chemotherapy followed by radical hysterectomy or radiotherapy. According to the evaluation by MRI, complete response was achieved in 2 cases and partial response in 17 cases. Eventually the response rate was 76%. The response rate was higher in squamous cell carcinomas (85%) than adenocarcinomas or adenosquamous carcinomas (67%). The histological effect is superior in squamous cell carcinomas than adenocarcinomas or adenosquamous carcinomas. Radical hysterectomy was performed in 5 cases of 11 (45%) stage III-IVa cervical cancers. There was no correlation between tumor size and response to NAC. NAC therapy may be useful therapy in advanced cervical cancers, especially squamous cell carcinomas.
25例晚期宫颈癌(IIb-IVa期)患者接受了新辅助化疗,随后进行了根治性子宫切除术或放射治疗。根据MRI评估,2例达到完全缓解,17例达到部分缓解。最终缓解率为76%。鳞状细胞癌的缓解率(85%)高于腺癌或腺鳞癌(67%)。鳞状细胞癌的组织学效果优于腺癌或腺鳞癌。11例III-IVa期宫颈癌患者中有5例(45%)进行了根治性子宫切除术。肿瘤大小与对新辅助化疗的反应之间无相关性。新辅助化疗可能是晚期宫颈癌尤其是鳞状细胞癌的有效治疗方法。